Navigation Links
Diabetes Experts Issue New Recommendations for Inpatient Glycemic Control - Call for Systemic Changes in Hospitals Nationwide
Date:5/8/2009

JACKSONVILLE, Fla. and ALEXANDRIA, Va., May 8 /PRNewswire-USNewswire/ -- New recommendations released today by a consensus group of the American Association of Clinical Endocrinologists (AACE) and the American Diabetes Association (ADA) are calling for major changes in the way health care professionals treat hospitalized patients with high blood glucose (sugar) levels. The authors recommend revised glucose targets of 140-180 mg/dL in the ICU setting, and between 100-180 mg/dL for most patients admitted to general medical-surgical wards.

(Logo: http://www.newscom.com/cgi-bin/prnh/20090324/DC88061LOGO-b)

The recommendations, which were published online today and will appear in the June issues of Endocrine Practice (Link here) and Diabetes Care (Link here), come at a time when attempts to intensively manage glucose targets in the ICU setting have shown inconsistent results in patient outcomes. Several recent randomized controlled clinical trials in critically ill patients in ICUs with diabetes or elevated blood glucose levels have failed to show a significant improvement in mortality with intensive insulin therapy to achieve near normal glucose levels. Moreover, a large newly-published randomized controlled trial showed an increase in mortality risk associated with intensive control of glycemia targeting blood glucose of 80-110 mg/dL. These outcomes have raised concerns regarding specific glycemic targets and the means for achieving them in both critically and non-critically ill patients.

Recognizing the importance of glycemic control across the continuum of care, experts from AACE and ADA were invited to develop an upda
'/>"/>

SOURCE American Association of Clinical Endocrinologists; American Diabetes Association
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. MacroGenics Begins Global Phase 2/3 Protege Study in Recent-onset Type 1 Diabetes Mellitus
2. Sarasotas Roskamp Institute Releases Study Defining a Mechanism for Development of Obesity and the Metabolic Syndrome, Forerunners of Type 2 Diabetes
3. The Heart, Diabetes, And Weight Loss Centers of New York Introduce the New Science of Metabolic Diagnosis and Weight Management
4. Isis Initiates Phase 1 Study of ISIS 325568 Targeting Glucagon Receptor to Treat Type 2 Diabetes
5. Diabetes Research Institute Invention Promotes Growth of Stem Cells into Insulin-Producing Cells
6. Cleveland Clinic Study Shows the Diabetes Drug Pioglitazone Reduces Risk of Death, Heart Attack and Stroke, but Increases Risk of Heart Failure
7. ACTOS(R) (pioglitazone HCl) Demonstrates Reduced Risk of Ischemic Cardiovascular Disease in Patients with Type 2 Diabetes
8. Nastech Pharmaceutical Company Announces Initiation of Phase 2 Clinical Trial for Insulin Nasal Spray to Treat Diabetes
9. DiObex Begins Dosing Patients in Phase 2b Trial of Type 2 Diabetes Drug
10. Synvista Therapeutics Alagebrium Shows Potential for use in Treating Diabetes-Related Gastrointestinal Complications
11. Synvista Collaboration Demonstrates in Preclinical Studies the Mechanism for Defective Cholesterol Transport in Patients with Diabetes

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/25/2009)...alif.,Nov.25/PRNewswire/--PraxisElectronicMedicalR...myofFamilyPhysicians,(AAFP)FamilyPracticeManagemen...icalquality,healthmaintenance,anddiseasemanagement...soranked#1amongdoctorsindicatingtheirEMRhadapositi...orankednumberoneinthecountryinprovidingexcellenttr...
(Date:11/25/2009)...J.,Nov.25/PRNewswire-FirstCall/--Pharmasset,Inc.(N...ommittedtodiscovering,developingandcommercializing...resultsforthefiscalyearendedSeptember30,2009.AtSep...equivalentsandshortterminvestments. ,, Pipelin...hase2bTrial ,, InlateNovember2009,anindepende...
(Date:11/25/2009)...N.J.,Nov.25/PRNewswire/--TheFDAgrantedtraditionala...nucleosidereversetranscriptaseinhibitor(NNRTI).INT...reatment-experiencedadultswhoareexperiencingvirolo...erantiretroviral(ARV)agents.Thetraditionalapproval...T-1andDUET-2.INTELENCEiscurrentlymarketedintheU.S....
Breaking Medicine Technology:Praxis EMR Wins Top Rankings in 2009 AAFP EHR User Satisfaction Survey 2Pharmasset Reports Fiscal Year End 2009 Financial Results 2Pharmasset Reports Fiscal Year End 2009 Financial Results 3Pharmasset Reports Fiscal Year End 2009 Financial Results 4Pharmasset Reports Fiscal Year End 2009 Financial Results 5Pharmasset Reports Fiscal Year End 2009 Financial Results 6Pharmasset Reports Fiscal Year End 2009 Financial Results 7Pharmasset Reports Fiscal Year End 2009 Financial Results 8U.S. Food And Drug Administration (FDA) Grants Traditional Approval for INTELENCE(R) (etravirine) 2U.S. Food And Drug Administration (FDA) Grants Traditional Approval for INTELENCE(R) (etravirine) 3U.S. Food And Drug Administration (FDA) Grants Traditional Approval for INTELENCE(R) (etravirine) 4Vein Condition May Mask Serious Clot Disorder 52152 1Vein Condition May Mask Serious Clot Disorder 52152 2High Salt Diet Dampens Effects of Blood Pressure Drugs 52147 1High Salt Diet Dampens Effects of Blood Pressure Drugs 52147 2High Salt Diet Dampens Effects of Blood Pressure Drugs 52147 3PFCD Urges Congress to Address Real Cost Driver in Health Reform in Light of New CBO Statement 52143 1PFCD Urges Congress to Address Real Cost Driver in Health Reform in Light of New CBO Statement 52143 2
...stria, Sept. 5 Four analyses of three-year,follow...ng Coronary Stent,may be considered an appropriate...ockages in two or more coronary arteries (multives...k at the European Society of Cardiology,Congress 2...sought to assess the long-term impact of the,CYPHE...
...cal and Phase 1 Data Scheduled for Presentation at...-19, 2007 -, CARLSBAD, Calif., Sept. 4 Ardea Bio...that it has successfully completed,Phase 1 single-...ct, and,drug-interaction studies of RDEA806, a nov...tor (NNRTI), in healthy volunteers. The data from...
Other Medicine Technology:Four Analyses of Three-Year Clinical Data Suggest CYPHER(R) Sirolimus-Eluting Coronary Stent May Provide Alternative to Surgery for Patients with Multivessel Disease 2Four Analyses of Three-Year Clinical Data Suggest CYPHER(R) Sirolimus-Eluting Coronary Stent May Provide Alternative to Surgery for Patients with Multivessel Disease 3Four Analyses of Three-Year Clinical Data Suggest CYPHER(R) Sirolimus-Eluting Coronary Stent May Provide Alternative to Surgery for Patients with Multivessel Disease 4Four Analyses of Three-Year Clinical Data Suggest CYPHER(R) Sirolimus-Eluting Coronary Stent May Provide Alternative to Surgery for Patients with Multivessel Disease 5Ardea Biosciences, Inc. Announces Completion of Phase 1 Clinical Trials of Novel Investigational HIV Drug RDEA806 2Ardea Biosciences, Inc. Announces Completion of Phase 1 Clinical Trials of Novel Investigational HIV Drug RDEA806 3
(Date:11/27/2009)...oldings has announced that it has become a nationa...largest nonprofit organizations dedicated to arthr... Delray Beach, FL (Vocus) Novem...HO), a company specializing in the marketing and r..., has announced today that is has become a nationa...
(Date:11/27/2009)...lth™ announced today that Spectrum Health (G...Enterprise orthopedic templating solution and its ... (PRWEB) November 27, 2009 -- Voyant H...(Grand Rapids, Michigan) has licensed its TraumaCa...s TraumaCad Extend workflow solution, to allow its...
(Date:11/26/2009)...Withcoldandfluseasonuponus,it,smoreimportantthanev...onsandavoidillness. ,, "Weneedtobeproactivenoto...lnessifwe,resick,"saidEileenFinerty,RN,MS,CIC(cert...ioncontrolandoccupationalhealthatHospitalforSpecia...Surgeryhasoneofthelowestinfectionratesofanyhospita...
(Date:11/26/2009)...can lead to strains or worse , , THURSDA...g wrong with stuffing your turkey full to bursting... your suitcase as you pack for holiday trips. ,....S. hospital emergency rooms, doctors, offices, cl...ated injuries, such as muscle strains, pulls and t...
(Date:11/26/2009)...riangle Dental (RTDental), a leading dental group ...d the expansion of its services to include LUMINEE...llan. , Durham, NC (PR...ounce that Dr. Doug Macmillan, an experienced LUM...advanced training seminar. RTDental’s abili...
Breaking Medicine News(10 mins):Health News:XenaCare Holdings Announces National Sponsorship of the Arthritis Foundation 2Health News:XenaCare Holdings Announces National Sponsorship of the Arthritis Foundation 3Health News:XenaCare Holdings Announces National Sponsorship of the Arthritis Foundation 4Health News:Voyant Health Announces: Spectrum Health Licenses TraumaCad Enterprise and TraumaCad Extend 2Health News:Voyant Health Announces: Spectrum Health Licenses TraumaCad Enterprise and TraumaCad Extend 3Health News:Infection-Control Strategies at Leading Hospital Can be Adapted for Everyday Use 2Health News:Infection-Control Strategies at Leading Hospital Can be Adapted for Everyday Use 3Health News:Pack Right for the Holidays to Avoid the ER 2Health News:Dr. Douglas Macmillan Now Providing LUMINEERS at Research Triangle Dental 2
...lly eliminated brain tumors from mice in a dramati...ent bone damage in younger mice. The researcher wh...w finding raises concerns about using similar drug... at The Childrens Hospital of Philadelphia, led th...
...iting, Child-Friendly Online Information Source fo...ofessionals http://www....le, one of the world,s,premier strategic branding ...urces about childhood cancer, blood,disorders, and...
...d and stop the collateral lung damage that can occ...focus of a new study. , When a babys heart defect...d vessels are made, apparently to handle the incre... the system gets shut down and the lungs dont get ...
...ers at Duke University Medical Center say they may... cardiovascular health in women than in men. , Th...Behavior and Immunity, found that poor sleep is as... also found that these associations are significan...
... The Children,s,Hospital of Philadelphia is please...ition of Chief Nursing Officer. The appointment fo...p://www.newscom.com/cgi-bin/prnh/20080310/DC16185 ...enter, where she also held a joint appointment in ...
...0 Gentiva Health,Services, Inc. (Nasdaq: GTIV ),...me health services, announced today that it is sch...Tuesday, March 18, 2008 at the,Lehman Brothers Ele...d by visiting http://investors.gentiva.com/events...
Other Medicine News:Health News:Potential brain cancer drug for children may damage bones 2Health News:Potential brain cancer drug for children may damage bones 3Health News:Siegel+Gale Designs New 'HOPE Portal' for Childrens Hospital Los Angeles 2Health News:Siegel+Gale Designs New 'HOPE Portal' for Childrens Hospital Los Angeles 3Health News:Lung damage in babies with congenital heart disease under study 2Health News:Lung damage in babies with congenital heart disease under study 3Health News:Poor sleep more dangerous for women 2Health News:Poor sleep more dangerous for women 3Health News:The Children's Hospital of Philadelphia Appoints New Chief Nursing Officer 2Health News:Gentiva(R) Health Services to Present March 18th at Lehman Brothers Eleventh Annual Global Healthcare Conference in Miami 2Health News:Gentiva(R) Health Services to Present March 18th at Lehman Brothers Eleventh Annual Global Healthcare Conference in Miami 3
5 mm and 10 mm Laparoscopy Instrument Repair and Reinsulation
...er optics reduce the light output to your surgical...ptical clarity that is so vital. Frequent inspecti...l to prevent further damage and more extensive and...echnician can inspect your cables for you at no ch...
Rigid Endoscope Repair
...inspects your equipment upon arrival. Our technici...ovides you with a thorough customer quote. We resp...so well help you prioritize repairs. With customer... , ISI uses only OEM or widely approved equivale...
Medicine Products: